4-(2-Bromophenyl)oxazole, 95%, 250mg

Methyl 4-(4-(1-aminoethyl)-2-methoxy-5-nitrophenoxy)butanoate hydrochloride, 97%, 1g

(S)-tert-Butyl 2-amino-5-(((benzyloxy)carbonyl)amino)pentanoate hydrochloride, 95.0%, 250mg

(4-ethoxyphenyl)(2-furyl)methanone, 95.0%, 1g

3-cyclopropyl-4-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 250mg

2-(2,3-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 10g

2-(Bromomethyl)-1-methoxy-4-nitrobenzene, 95.0%, 250mg

Warning symbol according to ISO 7010 Individual label, Radioactive substances or ionizing radiation, Side length 200 mm, 1 piece

2-Chloro-3-nitrobenzaldehyde, 95.0%, 100g

Warning symbol according to ISO 7010 Individual label, Magnetic field, Side length 100 mm, 1 piece

1,5-Diphenylcarbazide, min. 97%, pa, ACS, 100 g, plastic packaging.

(3-beta, 5-alpha)-3-Hydroxypregnan-20-one, 5g

1,3,2-Dioxaborolane, 2-[4-chloro-3-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-, 95%, 5g